Abcellera Biologics Inc share price logo

Abcellera Biologics Inc Share Price

NASDAQ: ABCL

Small Cap

$4.76

+0.42

(+9.54%)

as on

Abcellera Biologics Inc Stock Performance

as on September 17, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $4.35
    $4.85
    downward going graph

    8.61%

    Downside

    1.89%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.89
    $5.82
    downward going graph

    60.28%

    Downside

    22.27%

    Upside

    downward going graph

Abcellera Biologics Inc share price movements today

Previous Close
$4.35
Open
$4.36
Volume
5.7M
Day's Low - High
$4.35 - $4.85
52 Week Low - High
$1.89 - $5.82

Abcellera Biologics Inc Historical Returns

1 Month Return
-5.23 %
3 Month Return
+ 37.66 %
1 Year Return
+ 62.31 %
3 Year Return
-57.97 %
5 Year Return
0 %

Abcellera Biologics Inc Stock Fundamentals & Key Indicators

Check Abcellera Biologics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.3B

EPS (TTM)

-0.5867

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.46%

PE Ratio (TTM)

-4.86

Industry PE ratio

-3.947831325301205

P/B Ratio

0

PEG Ratio

0

EBITDA

-218.4M

Revenue (TTM)

32.9M

Profit Margin

0.00%

Return On Equity TTM

15107500.00%

Abcellera Biologics Inc Stock Valuation

Track how Abcellera Biologics Inc P/E has moved over time to understand its valuation trends.

Abcellera Biologics Inc in the last 5 years

  • Overview

  • Trends

Lowest (13.44x)

June 30, 2022

Today (-4.86x)

September 16, 2025

Industry (-3.95x)

September 16, 2025

Highest (115.25x)

December 31, 2020

LowHigh

Today’s Price to Earnings Ratio: -4.86x

Abcellera Biologics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Abcellera Biologics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Abcellera Biologics Inc image
Abcellera Biologics Inc
BUY$1.3BNA-4.860.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$61.1B251.26%-505.15-12.96%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$38.7BNANA-3.89%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$101.2B47.46%28.0931.86%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$59.6B0.6%14.131.37%

Stock Returns calculator for Abcellera Biologics Inc Stock including INR - Dollar returns

The Abcellera Biologics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Abcellera Biologics Inc investment value today

Current value as on today

₹1,82,479

Returns

₹82,479

(+82.48%)

Returns from Abcellera Biologics Inc Stock

₹77,612 (+77.61%)

Dollar Returns*

₹4,867 (+4.87%)

Analyst Recommendation on Abcellera Biologics Inc Stock

Based on 15 analysts

BUY

93.33%

Buy

6.67%

Hold

0.00%

Sell

Based on 15 analysts, 93.33% of analysts recommend a 'BUY' rating for Abcellera Biologics Inc. Average target price of $9.33

Abcellera Biologics Inc Share Price Target

Get share price movements and forecasts by analysts on Abcellera Biologics Inc.

What analysts predicted

48.98%UPSIDE

Target Price

$9.33

Current Price

$4.76

Analyzed by

15 Analysts

Target

$9.33

Abcellera Biologics Inc target price $9.33, a slight upside of 48.98% compared to current price of $4.76. According to 15 analysts rating.

Abcellera Biologics Inc Stock's Interest Amongst Investors

Investment in Abcellera Biologics Inc Shares on INDmoney has dropped by -48.79% over the past 30 days, indicating reduced transactional activity.

Time period: to

Change:-48.79% versus previous 30 day period

Search interest for Abcellera Biologics Inc Stock has decreased by -69% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-69% versus previous 30 day period

Abcellera Biologics Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
12
10
6
9
9
7
6
5
4
17
Gross Profit
-40
2
0
0
3
-30
-31
-8
-38
17
Operating Income
-61
-51
-54
-66
-54
-93
-93
-72
-105
-49
EBITDA
-59
-39
-44
-58
-48
-56
-51
-33
-39
-38
Interest Expense
16
-
-
16
-
-
-
-
8
-
Depreciation
7
7
7
9
6
38
38
13
6
7
Income Before Tax
-48
-38
-39
-48
-42
-48
-62
-46
-52
-36
Income Tax Expense
-8
-7
-10
-1
-2
-11
-11
-12
-7
-1
Net Income
-40
-30
-28
-47
-40
-36
-51
-34
-45
-34
Net Profit Margin
-328.99%
-303.58%
-433.55%
-513.67%
-407.98%
-504.30%
-785.42%
-677.43%
-1077.24%
-203.27%

Abcellera Biologics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
8
11
233
11
485
38
28
Gross Profit
3
1
206
11
418
7
-68
Operating Income
0
-4
156
-4
216
-237
-314
EBITDA
0
0
169
0
272
-192
-204
Interest Expense
0
0
6
0
4
-
-
Depreciation
0
1
5
17
33
30
96
Income Before Tax
0
-2
157
-2
239
-174
-200
Income Tax Expense
1
0
38
65
80
-27
-37
Net Income
0
-2
118
-2
158
-146
-162
Net Profit Margin
3.50%
-20.84%
51.00%
-19.04%
32.66%
-385.00%
-564.83%

Abcellera Biologics Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-30
-28
-47
-40
-36
-51
-34
-45
-34
Operating Cash Flow
19
0
-19
-41
-29
-28
-8
-11
-32
Investing Cash Flow
-34
-12
-24
29
51
3
35
7
-31
Financing Cash Flow
0
6
3
2
2
3
4
5
-3
Change in Cash
-13
-7
-39
-11
24
-21
29
2
-66

Abcellera Biologics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-2
118
153
158
-146
-162
Operating Cash Flow
2
22
244
277
-43
-108
Investing Cash Flow
-5
-119
-332
-352
-221
121
Financing Cash Flow
0
683
-3
-1
10
12
Change in Cash
-2
586
-92
-86
-254
23

Global Institutional Holdings in Abcellera Biologics Inc

Funds
Holdings
Baker Bros Advisors LP
9.22%
ING Investment Management LLC
7.11%
UBS Asset Mgmt Americas Inc
5.25%
Capital World Investors
4.47%
Baillie Gifford & Co Limited.
3.47%
See all

Insights on Abcellera Biologics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -45.62M → -34.72M (in $), with an average increase of 31.4% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, ABCL stock has moved up by 72.6%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 4.23M → 17.08M (in $), with an average increase of 75.2% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 70.6% return, outperforming this stock by 8.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 174.5%

About Abcellera Biologics Inc

abcellera is a canadian biotechnology company focused on accelerating the discovery of monoclonal antibody (mabs) therapeutics. antibodies are molecules that are naturally produced by the immune system of humans or animals to fight off infection and disease. the unique property of antibodies is that they can specifically recognize and target diseased cells or pathogens, making them precise and highly effective drugs with low side effects for the treatment of cancer, autoimmune disorders and infections. the immune system is capable of making billions to trillions of unique antibodies, each produced by a single immune cell. of these, only a select few are suitable for therapeutic applications. finding these rare antibodies presents a major roadblock in the development of new therapeutics. abcellera addresses this bottleneck by using microfluidic technology for the rapid and high-throughput analysis of antibodies directly from single cells. abcellera is a spinoff from dr. carl hansen’
OrganisationAbcellera Biologics Inc
Headquarters150 West 4th Ave, Vancouver, BC, Canada, V5Y 1G6
IndustryHealthcare
CEODr. Carl L.G. Hansen Ph.D.
E-voting on sharesClick here to vote

Key Management of Abcellera Biologics Inc

Name

Title

Dr. Carl L.G. Hansen Ph.D.

CEO, President & Chairperson

Dr. Veronique Lecault Ph.D.

CTO & Director

Ms. Tiffany Chiu B.Sc., Ph.D.

Vice President of Communications

Mr. Murray McCutcheon Ph.D.

Senior Vice President of Partnering

Graham Craig M.Sc.

Director of Corporate Development

Caitlin Webster CIPD, M.Sc.

Director of Talent Development

Mr. Andrew Booth M.B.A.

Chief Financial Officer

Mr. Tryn T. Stimart Esq., J.D., M.Sc.

Chief Legal Officer, CCO, Compliance Officer, Corporate Secretary & Privacy Officer

Mr. Andrew Knowles M.Sc.

VP of Operations

Marcie Thiessen CPA, CGA

Senior Director of Finance & Accounting

FAQs

What is Abcellera Biologics Inc share price today?

Abcellera Biologics Inc share price today is $4.76 as on at the close of the market. Abcellera Biologics Inc share today touched a day high of $4.85 and a low of $4.35.

What is the 52 week high and 52 week low for Abcellera Biologics Inc share?

Abcellera Biologics Inc share touched a 52 week high of $5.82 on and a 52 week low of $1.89 on . Abcellera Biologics Inc stock price today i.e. is closed at $4.76,which is 18.21% down from its 52 week high and 151.77% up from its 52 week low.

What is Abcellera Biologics Inc's market capitalisation today?

Abcellera Biologics Inc market capitalisation is $0.00T as on .

How to invest in Abcellera Biologics Inc Stock (ABCL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Abcellera Biologics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Abcellera Biologics Inc Shares that will get you 0.3151 shares as per Abcellera Biologics Inc share price of $4.76 per share as on September 17, 2025 at 1:29 am IST.

What is the minimum amount required to buy Abcellera Biologics Inc Stock (ABCL) from India?

Indian investors can start investing in Abcellera Biologics Inc (ABCL) shares with as little as ₹88.042 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Abcellera Biologics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Abcellera Biologics Inc share’s latest price of $4.76 as on September 17, 2025 at 1:29 am IST, you will get 2.1008 shares of Abcellera Biologics Inc. Learn more about fractional shares .